![Kazumi Shiosaki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kazumi Shiosaki
Directeur Général chez
Redona Therapeutics, Inc.
Profil
Kazumi Shiosaki was the founder of Mitobridge, Inc., founded in 2013, serving as President, Chief Executive Officer & Director.
Current jobs include President, Chief Executive Officer & Director at Redona Therapeutics, Inc. since 2016; Managing Director at MPM Asset Management LLC since 2003; and Trustee at Sanford Burnham Prebys Medical Discovery Institute since 2017.
Former jobs include President & Director at Sideris Pharmaceuticals, Inc. from 2013 to 2014; Managing Director at MPM BioImpact LLC; Director at ForteBio, Inc.; Independent Director at Epizyme, Inc. from 2012 to 2014; Director at CoStim Pharmaceuticals, Inc.; Principal at Abbott Laboratories; Senior Vice President at Millennium Pharmaceuticals, Inc.; and Scientific Advisor at Hatteras Venture Partners.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from Whitman College.
Postes actifs de Kazumi Shiosaki
| Sociétés | Poste | Début |
|---|---|---|
MPM Asset Management LLC
 MPM Asset Management LLC Financial ConglomeratesFinance Provides venture Capital | Corporate Officer/Principal | 01/01/2003 |
Sanford Burnham Prebys Medical Discovery Institute
 Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Conducts medical research | Directeur/Membre du Conseil | 29/04/2017 |
Redona Therapeutics, Inc.
 Redona Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics for cancer and autoimmune diseases | Directeur Général | 01/01/2016 |
Anciens postes connus de Kazumi Shiosaki
| Sociétés | Poste | Fin |
|---|---|---|
Hatteras Venture Partners
 Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments. | Corporate Officer/Principal | 31/12/2015 |
| EPIZYME, INC. | President | 18/05/2012 |
ForteBio, Inc.
 ForteBio, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets biomolecular analysis products | Directeur/Membre du Conseil | 28/11/2012 |
CoStim Pharmaceuticals, Inc.
 CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Directeur/Membre du Conseil | - |
Sideris Pharmaceuticals, Inc.
 Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on development of therapeutics for the treatment of transfusion-related iron overload | President | 09/01/2014 |
Formation de Kazumi Shiosaki
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Sideris Pharmaceuticals, Inc.
Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on development of therapeutics for the treatment of transfusion-related iron overload | Health Technology |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
MPM Asset Management LLC
MPM Asset Management LLC Financial ConglomeratesFinance Provides venture Capital | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitman College
 Whitman College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ForteBio, Inc.
ForteBio, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets biomolecular analysis products | Health Technology |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments. | Finance |
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Conducts medical research | Health Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Health Technology |
Mitobridge, Inc.
 Mitobridge, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics for cancer and autoimmune diseases | Health Technology |
